Efficacy of two rurioctocog alfa prophylactic regimens following on-demand treatment in patients aged ≥14 years with severe haemophilia A

Trial Profile

Efficacy of two rurioctocog alfa prophylactic regimens following on-demand treatment in patients aged ≥14 years with severe haemophilia A

Not stated
Phase of Trial: Phase IV

Latest Information Update: 09 Aug 2011

At a glance

  • Drugs Rurioctocog alfa (Primary)
  • Indications Haemophilia A
  • Focus Therapeutic Use
  • Acronyms RAHF-PFM
  • Most Recent Events

    • 09 Aug 2011 New trial record
    • 28 Jul 2011 Results presented at the 23rd Congress of the International Society on Thrombosis and Haemostasis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top